Breast arterial calcification: a marker of medial vascular calcification in chronic kidney disease

Valerie Duhn1, Ellen T D'Orsi, Samuel Johnson

  • 1Renal Division, Department of Medicine, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA.

Insights

Breast arterial calcification (BAC) is a reliable indicator of medial vascular calcification in chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Its prevalence significantly increases with ESKD and advanced CKD.

Area of Science:

  • Vascular Biology
  • Nephrology
  • Radiology

Background:

  • Distinguishing intimal (atherosclerotic) from medial vascular calcification is crucial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD).
  • Previous studies have not differentiated these calcification types, leaving their prevalence and clinical significance in CKD/ESKD unknown.

Purpose of the Study:

  • To investigate breast arterial calcification (BAC) as a marker for medial vascular calcification.
  • To determine the prevalence and clinical significance of medial vascular calcification in CKD and ESKD using mammography.

Main Methods:

  • Histological analysis of breast tissue and visual assessment of mammograms/radiographs for arterial calcification in CKD/ESKD patients.
  • Comparison of BAC prevalence in women with ESKD versus controls matched for age, race, and diabetes.
  • Evaluation of BAC prevalence in relation to CKD stage and duration of ESKD.

Main Results:

  • Medial calcification was present in all analyzed specimens from CKD/ESKD patients; intimal calcification was absent.
  • BAC was significantly more prevalent in women with ESKD (63%) compared to controls (17%).
  • BAC prevalence increased with ESKD duration and was higher in advanced CKD stages, correlating strongly with peripheral arterial calcification (PAC).

Conclusions:

  • Breast arterial calcification (BAC) serves as a specific and valuable marker for medial vascular calcification.
  • The prevalence of medial vascular calcification, indicated by BAC, is substantially elevated in end-stage kidney disease (ESKD) and advanced chronic kidney disease (CKD).
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...